Abstract:Motivation: Computational drug repositioning is a cost-effective strategy to identify novel indications for existing drugs. Drug repositioning is often modeled as a recommendation system problem. Taking advantage of the known drug–disease associations, the objective of the recommendation system is to identify new treatments by filling out the unknown entries in the drug–disease association matrix, which is known as matrix completion. Underpinned by the fact that common molecular pathways contribute to many different diseases, the recommendation system assumes that the underlying latent factors determining drug–disease associations are highly correlated. In other words, the drug–disease matrix to be completed is low-rank. Accordingly, matrix completion algorithms efficiently constructing low-rank drug–disease matrix approximations consistent with known associations can be of immense help in discovering the novel drug–disease associations. Results: In this article, we propose to use a bounded nuclear norm regularization (BNNR) method to complete the drug–disease matrix under the low-rank assumption. Instead of strictly fitting the known elements, BNNR is designed to tolerate the noisy drug–drug and disease–disease similarities by incorporating a regularization term to balance the approximation error and the rank properties. Moreover, additional constraints are incorporated into BNNR to ensure that all predicted matrix entry values are within the specific interval. BNNR is carried out on an adjacency matrix of a heterogeneous drug–disease network, which integrates the drug–drug, drug–disease and disease–disease networks. It not only makes full use of available drugs, diseases and their association information, but also is capable of dealing with cold start naturally. Our computational results show that BNNR yields higher drug–disease association prediction accuracy than the current state-of-the-art methods. The most significant gain is in prediction precision measured as the fraction of the positive predictions that are truly positive, which is particularly useful in drug design practice. Cases studies also confirm the accuracy and reliability of BNNR. Availability and implementation: The code of BNNR is freely available at https://github.com/ BioinformaticsCSU/BNNR. Contact: jxwang@mail.csu.edu.cn Supplementary information: Supplementary data are available at Bioinformatics online.

DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion

Drug repositioning based on the target microRNAs using bilateral-inductive matrix completion

Computational Drug Repositioning Based on Multi-Similarities Bilinear Matrix Factorization.

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

Drug Repositioning Based on Multi-View Learning with Matrix Completion

Heterogeneous graph inference with matrix completion for computational drug repositioning

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

ITRPCA: a New Model for Computational Drug Repositioning Based on Improved Tensor Robust Principal Component Analysis.

A weighted bilinear neural collaborative filtering approach for drug repositioning

DIVERSE: Bayesian Data IntegratiVE learning for precise drug ResponSE prediction

DDAPRED: a Computational Method for Predicting Drug Repositioning Using Regularized Logistic Matrix Factorization

Predicting drug-target interactions using matrix factorization with self-paced learning and dual similarity information

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Inductive Matrix Completion for Predicting Adverse Drug Reactions (adrs) Integrating Drug–target Interactions

Drug Repositioning Via Matrix Completion with Multi‐view Side Information

The Balanced Matrix Factorization for Computational Drug Repositioning

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

PIMD: An Integrative Approach for Drug Repositioning Using Multiple Characterization Fusion

Op-cbio190335 455..463